PhaseBio Pharmaceuticals, Inc.
USD0.07
+0.00 (+0.00%)
CEO
Jonathan Mow
IPO Date
2018-10-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.08
Prev. Close
$0.07
Day Low
$0.07
Day High
$0.09
52W Low
$0.04
52W High
$4.08
Volume
8.60M
| 2,538 |
| $0.00 |
| 19 May 2023 | Sapir Alex | director | M-Exempt | Acquired | 3,750 | $0.00 |
| 19 May 2023 | Sapir Alex | director | M-Exempt | Disposed | 3,750 | $0.00 |
| 19 May 2023 | Thorp Clay | director | M-Exempt | Acquired | 3,750 | $0.00 |
| 19 May 2023 | Thorp Clay | director | M-Exempt | Acquired | 3,750 | $0.00 |
| 19 May 2023 | van den Broek Richard | director | M-Exempt | Disposed | 3,750 | $0.00 |
| 19 May 2023 | van den Broek Richard | director | A-Award | Acquired | 3,750 | $0.00 |
| 19 May 2023 | Hutson Nancy J | director | M-Exempt | Acquired | 3,750 | $0.00 |
| 19 May 2023 | Hutson Nancy J | director | M-Exempt | Disposed | 3,750 | $0.00 |